Avidity Biosciences Inc (RNA)
31.35
-0.29
(-0.92%)
USD |
NASDAQ |
Dec 24, 16:00
Avidity Biosciences Free Cash Flow: -188.51M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | -1.352B |
| Sarepta Therapeutics Inc | -480.40M |
| Dyne Therapeutics Inc | -244.42M |
| Entrada Therapeutics Inc | -17.46M |
| Catalyst Pharmaceuticals Inc | 221.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -65.62M |
| Cash from Investing (Quarterly) | -482.41M |
| Cash from Financing (Quarterly) | 342.46M |
| Free Cash Flow Per Share (Quarterly) | -0.5456 |
| Free Cash Flow to Equity (Quarterly) | -67.32M |
| Free Cash Flow Yield | -6.11% |